Using clinical risk factors and bone mineral density to determine who among patients undergoing bone densitometry should have vertebral fracture assessment

por Vokes, T. J., Gillen, D. L.
Publicado 2010

Prevalence of vertebral fractures on chest radiographs of elderly African American and Caucasian women

por Lansdown, D., Bennet, B., Thiel, S., Ahmed, O., Dixon, L., Vokes, T. J.
Publicado 2010

Effects of parathyroid hormone rhPTH(1–84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study

por Clarke, Bart L., Vokes, Tamara J., Bilezikian, John P., Shoback, Dolores M., Lagast, Hjalmar, Mannstadt, Michael
Publicado 2016

SUN-380 Opportunistic Screening with Abdominal CT in Patients with Diabetes Can Identify Those at High Risk of Osteoporosis and Osteopenia

por Jain, Rajesh, Lee, Eunjae, Mathai, Christine, Dako, Farouk, Gogineni, Preethi, Weiner, Mark G, Vokes, Tamara J
Publicado 2020

Association of Loneliness With Falls: A Study of Older US Adults Using the National Social Life, Health, and Aging Project

por Zeytinoglu, Meltem, Wroblewski, Kristen E., Vokes, Tamara J., Huisingh-Scheetz, Megan, Hawkley, Louise C., Huang, Elbert S.
Publicado 2021

Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism

por Vokes, Tamara J, Mannstadt, Michael, Levine, Michael A, Clarke, Bart L, Lakatos, Peter, Chen, Kristina, Piccolo, Rebecca, Krasner, Alan, Shoback, Dolores M, Bilezikian, John P
Publicado 2017

Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism

por Mannstadt, Michael, Clarke, Bart L, Bilezikian, John P, Bone, Henry, Denham, Douglas, Levine, Michael A, Peacock, Munro, Rothman, Jeffrey, Shoback, Dolores M, Warren, Mark L, Watts, Nelson B, Lee, Hak-Myung, Sherry, Nicole, Vokes, Tamara J
Publicado 2019

Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism

por Watts, Nelson B, Bilezikian, John P, Bone, Henry G, Clarke, Bart L, Denham, Douglas, Levine, Michael A, Mannstadt, Michael, Peacock, Munro, Rothman, Jeffrey G, Vokes, Tamara J, Warren, Mark L, Yin, Shaoming, Sherry, Nicole, Shoback, Dolores M
Publicado 2023

SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransCon PTH, a Long-Acting PTH, in Patients With Hypoparathyroidism

por Khan, Aliya Aziz, Rejnmark, Lars, Schwarz, Peter E, Vokes, Tamara J, Clarke, Bart Lyman, Rubin, Mishaela Ruth, Hofbauer, Lorenz C, Erikson, Erik, Palermo, Andrea, Pagotto, Uberto, Marcocci, Claudio, Ahmed, Intekhab, Mourya, Sanchita, Markova, Denka, Karpf, David B
Publicado 2020

TransCon PTH as a Hormone Replacement Therapy for Patients with Hypoparathyroidism: 6-Month Update from the PaTH Forward Open-Label Extension

por Rubin, Mishaela R, Rejnmark, Lars, Schwarz, Peter E, Vokes, Tamara J, Clarke, Bart, Ahmed, Intekhab, Hofbauer, Lorenz C, Palermo, Andrea, Marcocci, Claudio, Pagotto, Uberto, Eriksen, Erik F, Mourya, Sanchita, Markova, Denka, Pihl, Susanne, Shu, Aimee D, Khan, Aliya
Publicado 2021

SAT-399 Baseline Characteristics from the Observational PARADIGHM Registry of Patients with Chronic Hypoparathyroidism

por Clarke, Bart L, Rejnmark, Lars, Ing, Steven W, Brandi, Maria Luisa, Björnsdottir, Sigridur, Hofbauer, Lorenz C, Houillier, Pascal, Khan, Aliya A, Levine, Michael A, Mannstadt, Michael, Shoback, Dolores M, Vokes, Tamara J, Zhang, Pinggao, Marelli, Claudio, Germak, John, Gittoes, Neil
Publicado 2020

The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient char...

por Gittoes, Neil, Rejnmark, Lars, Ing, Steven W., Brandi, Maria Luisa, Björnsdottir, Sigridur, Hahner, Stefanie, Hofbauer, Lorenz C., Houillier, Pascal, Khan, Aliya A., Levine, Michael A., Mannstadt, Michael, Shoback, Dolores M., Vokes, Tamara J., Zhang, Pinggao, Marelli, Claudio, Germak, John, Clarke, Bart L.
Publicado 2021

OR23-05 Log-term Efficacy And Safety Of Transcon PTH In Adults With Hypoparathyroidism: 52-week Results From The Open-label Extension Of The Phase 3 Pathway Trial

por Clarke, Bart, Aziz Khan, Aliya, Ruth Rubin, Mishaela, Schwarz, Peter E, Vokes, Tamara J, Shoback, Dolores M, Gagnon, Claudia, Palermo, Andrea, Abbott, Lisa G, Hofbauer, Lorenz C, Kohlmeier, Lynn, Cetani, Filomena, Phil, Susanne, An, Xuebei, Raymond Smith, Alden, Lai, Bryant, Le, John, Ukena, Jenny, Sibley, Christopher, Shu, Aimee, Rejnmark, Lars
Publicado 2023